Cipargamin
Small molecule
Also known as KAE609
Evidence outlook
Mid- and late-stage studies completed
This drug has completed mid- or late-stage studies. Where a sponsor has not posted registry results, topline data typically arrives via company announcements; see News.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. The complete registry, including every study not featured here, is listed below.
Featured-trial selection for this indication is pending.
All registered studies
Every ClinicalTrials.gov study of this drug's own program. Studies backing a featured trial above are marked Featured; the rest aren't individually graded. Filter by which indication a study was run for, then browse by phase.
Phase 2 (9)
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
What this study did
Phase 1 (2)
What this study did
What this study did
Competitive landscape
This drug's own stage for Malaria: Phase 2. Competitors below are sorted furthest-along first.
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials | |
|---|---|---|---|---|---|---|
| Cipargamin: this drug | Phase 2 | Small molecule | PfATP4 | not yet graded | No reviewed efficacy summary in this indication | |
| Ganaplacide / Lumefantrine | Phase 3 | Small molecule | — | not yet graded | No reviewed efficacy summary in this indication | |
| GSK3772701 | Phase 2 | Undisclosed | — | not yet graded | No reviewed efficacy summary in this indication | |
| GSK4024484 | Phase 1 | Undisclosed | — | not yet graded | No reviewed efficacy summary in this indication | |
| INE963 | Phase 1(overall) | Small molecule | — | not yet graded | No reviewed efficacy summary in this indication | |
| GSK4425689 | —(overall) | Undisclosed | Circumsporozoite protein (CSP) | not yet graded | No reviewed efficacy summary in this indication |
Upcoming events
(1 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Follow Cipargamin to get an email as a readout nears, when a date moves, or when a study changes status. Needs a free account.
Add these readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.